As the life sciences industry moves through 2025, it presents a complex portrait of cautious optimism. While overall employment reached historic highs in 2024, the current market is marked by hiring freezes, intense competition, and a sharp increase in employer expectations (Intuition Labs, 2025). For pharmaceutical and biotech professionals, staying competitive requires not only technical skill but also strategic adaptability.

A Market in Flux

Biotech hiring has not fully rebounded from the “biotech winter” of 2022–2023. Job postings dropped 36% between mid-2023 and mid-2024, while layoffs from firms like Bristol Myers Squibb and Biogen injected a surplus of experienced professionals into the market (Intuition Labs, 2025). The result? More applicants chasing fewer openings.

Yet for many professionals, especially in biotech, the rebound remains elusive. One respondent to a 2024 BioSpace survey summed up the mood: “It’s never been more difficult to find a job in biopharma” (Intuition Labs, 2025).

Conversely, Asia-Pacific markets such as Singapore, Shanghai, and Bengaluru are seeing accelerated hiring driven by increased biotech investment and a shift toward localized R&D. “We’re seeing a transformation in the APAC region,” said Zenab Nessa, Vice President at EPM Scientific. “This growth has increased hiring, especially in research and regulatory affairs” (Siddiqui, 2025).

Emerging Roles & Career Models

New career paths reflect the fusion of scientific, regulatory, and data disciplines. Job titles like AI Drug Discovery Lead and Digital Health Integration Specialist are no longer futuristic—they’re current needs (Intuition Labs, 2025).

“AI in healthcare continues to be a significant area of growth, especially in drug discovery… We’re seeing a notable uptick in hiring for data science and bioinformatics roles… Unsurprisingly, cell and gene therapy, biosimilars, and digital health all continue to be sectors with the highest demand for talent,” said Nessa (Siddiqui, 2025).

What Employers Want in 2025

Key skills and attributes in demand include:

  • AI and Data Science: Life science companies are prioritizing candidates who can interpret, manage, and generate insights from complex datasets. Experience with tools like Python, R, and machine learning frameworks such as TensorFlow and PyTorch is increasingly sought after—not just in tech-facing roles, but across R&D, clinical, and commercial operations. Professionals capable of integrating computational methods into drug discovery, clinical trial design, or real-world evidence analysis are highly valued (Intuition Labs, 2025).
  • Regulatory Affairs: Roles related to compliance and approval are among the most resilient in the job market. Employers are actively seeking individuals with experience in investigational new drug (IND) submissions, Chemistry, Manufacturing and Controls (CMC) documentation, and knowledge of global regulatory harmonization standards. Familiarity with both FDA and EMA processes—and certifications such as RAC—are seen as strong assets, particularly in gene therapy and RNA-based drug sectors (Siddiqui, 2025).
  • Cross-functional Leadership: Employers are looking for professionals who can lead across departments and geographies, especially in the context of M&A integration or global product launches. Skills in strategic planning, stakeholder alignment, and budget oversight are increasingly important. As Karl Zhu of Hays China explained, “Professionals with forward-looking business insights and exceptional team leadership skills are the ideal choice for enterprises” (Siddiqui, 2025).
  • Digital Fluency: Proficiency with platforms such as Veeva (used for regulatory content and quality management), IQVIA (for clinical and commercial data analytics), and cloud-based Laboratory Information Management Systems (LIMS) is now a baseline expectation. These systems support critical operations such as real-time data tracking in clinical trials, document control for regulatory filings, and quality oversight in manufacturing. Employers increasingly expect candidates—particularly in roles across R&D, regulatory, and medical affairs—to demonstrate working fluency with these tools to enable integrated, data-driven decision-making.

Zenab Nessa also highlighted: “Candidates with experience across verticals, like clinical and regulatory, are particularly attractive to employers looking to consolidate hires” (Siddiqui, 2025).

GMDP Academy: Aligning Training with Industry Transformation

The GMDP Academy’s Certification in Medicines Development (CMD), developed in partnership with King’s College London, is strategically designed to prepare professionals for precisely these challenges. The 10-month program spans six essential modules, each aligned with real-world hiring demands:

  1. Fundamentals of Medicines Development
  2. Medical Affairs and Health Economics
  3. Drug Discovery, Exploratory and Confirmatory Development
  4. Clinical Trials: From Concept to Clinical Study Report
  5. Regulatory Affairs, Drug Safety, and Pharmacovigilance
  6. Medical Affairs as a Strategic Business Partner

Advanced modules include:

In addition to the full certification pathway, each module is also available as a standalone course. This offers flexibility for professionals who wish to upskill in a specific area—such as regulatory affairs, clinical trials, or digital health—without committing to the entire 10-month program. It’s an ideal option for those targeting career pivots or immediate project demands while maintaining a manageable learning schedule.

These modules target the very capabilities most sought after in 2025—from regulatory agility and interdisciplinary collaboration to AI readiness and business acumen.

Upskilling: The Strategic Edge

Companies like AstraZeneca, Merck, and Johnson & Johnson are investing in AI literacy and cross-functional training. GMDP Academy complements these efforts with structured, globally recognized training designed for professionals navigating high-stakes transitions and career pivots.

Looking Ahead

While the first half of 2025 remains slow in hiring, projections for the second half and beyond are stronger. A projected 32% life sciences job growth in Massachusetts by 2033 and surging APAC demand point to a resumption of expansion—though in more tech-enabled and cross-functional roles (Intuition Labs, 2025).

For Medicines Development professionals, this is a time to lead through learning. Those who build digital fluency, regulatory insight, and leadership capabilities today will be best positioned to shape the next era of pharmaceutical innovation.

References

Intuition Labs. (2025). The life sciences job market in 2025: Trends, skills, and outlook. https://intuitionlabs.ai/articles/life-sciences-job-market-2025

Siddiqui, A. (2025, May 31). Upskilling and flexibility are key to staying relevant as hiring grows. BioSpectrum Asia. https://www.biospectrumasia.com/analysis/26/26124/upskilling-and-flexibility-are-key-to-staying-relevant-as-hiring-grows.html

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred